Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Teijin Hooks Up with Chinese Firm on Small Molecule R&D
December 21, 2020
- Decision on Pfizer Vaccine Unlikely to Come before Japan Data Submission Slated by February
December 21, 2020
- Sanofi Files Sarclisa for Add'l Usage/Dosage in Japan
December 21, 2020
- Edirol Approved in China: Chugai
December 21, 2020
- Pfizer/BioNTech’s COVID-19 Vaccine Filed in Japan, Exceptional OK Eyed
December 18, 2020
- 5%-Plus Discrepancy Threshold for Off-Year Re-Pricing Draws Fire from Pharma, Wholesalers
December 18, 2020
- 2nd Death Reported for Tainted Itraconazole User, Doctor Says Causal Link Unlikely
December 18, 2020
- Otsuka Gets Japan, European Rights to Aurinia’s Lupus Nephritis Drug
December 18, 2020
- More Drug Makers Launching “Follow-on AGs”; Norvasc, Metgluco AGs Listed in December
December 18, 2020
- Gilead Japan Chief Disappointed by WHO’s Recommendation Against Veklury; Label Expansion Eyed for Moderately Ill Patients
December 18, 2020
- Opdivo/Yervoy Combo Approved for First-Line NSCLC Treatment in South Korea: Ono
December 18, 2020
- Taiho Gains Non-Exclusive Rights to Use PeptiDream’s Drug Discovery Platform
December 18, 2020
- Lenvima/Keytruda Pair Hits Survival Goal in Advanced Endometrial Cancer
December 17, 2020
- Kobayashi Kako Manually Managed Itraconazole Production; Hand-Written Record on Rilmazafone Mix-Up Found
December 17, 2020
- Takeda’s Eosinophilic Esophagitis Med Gets Priority Review in US
December 17, 2020
- Daiichi Sankyo CEO Says Lead ADC Projects on Track, Eager to Boost Portfolio
December 17, 2020
- Shionogi Kicks Off Japan PI/PII Study of COVID-19 Vaccine Candidate
December 17, 2020
- Industry Sees Flip-Flops on Supplies of Kobayashi Kako-Made Products
December 16, 2020
- UCB Japan to Independently Market New Products; Stand-Alone E Keppra Sales “Going Smoothly”: President
December 16, 2020
- MSD’s Zerbaxa Being Recalled, Shipments Halted after It Fails Sterility Testing
December 16, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…